The demand within the global market molecular cytogenetics has been escalating on account of key advancements in the field of genetics, gene therapy, and chromosomal study. Molecular cytogenetics is the field of biological sciences that deals with the study of chromosomal patterns with the help of molecular structures. It has significantly helped in studying several diseases related to aberrations in chromosomes of humans and animals. The field of research and diagnosis has also witnessed the unfurling of several new avenues due to advancements in the field of molecular cytogenetics. The precision and exactness offered by chromosomal cytogenetics is commendable, and this is another key factor that has popularised this technique.

The traditional technique of chromosomal banding has become outdated because of its low resolution and the risk of several chromosomes going undetected. Another key driver of demand within the global market for molecular cytogenetics is the development of nascent cytogenetic technologies such as aCHG and FISH. In recent times, research in the areas of gene mapping, disease trait analysis, and diagnosis has also become quite prominent which has aided the growth of the global market. Besides this, the domain of gene discovery is also gathering momentum which shall further escalate demand within the global market for molecular cytogenetics. Personalised medication and prognosis of tumours are amongst other fields that have bank on the successful execution molecular cytogenetics.

A report by Transparency Market Research (TMR) on the global market for molecular cytogenetics sheds light on several key factors that have aided the growth of this market. The report predicts that the global market molecular cytogenetics would expand at a stellar CAGR of 23.40% over the period between 2013 and 2019. Furthermore, the report states that the global molecular cytogenetics market is expected to accumulate revenues worth USD 1.9 billion by 2019, rising up from a  value of USD 469.2 million in 2012.

aCGH Technology Attracts More Demand than FISH Technology

Based on the technology used for molecular cytogenetics, the demand for aCGH technology has been higher as compared to FISH technology. This owes to the fact that array-competitive genomic hybridization (aCHG) offers a higher level of resolution than other similar technologies. Furthermore, diagnosis of diseases can also be done with a greater level of scrutiny through the deployment of aCGH technologies. On the basis of application, molecuclar cytogenetics is used for diagnosis, treatment, and study of cancers, genetic disorders, and for the production of personalised medicine. Amongst these applications, the molecular cytogenetics is extensively used for the development of personalised medications followed by the diagnosis of genetic disorders.

Europe to Emerge as Leading Regional Segment

The demand within the market for molecular cytogenetics in Europe has reached new heights due to regional developments in the field of genetics and presence of several research laboratories in the region. Furthermore, the market for molecular cytogenetics in Asia Pacific is also expected to bode well on account of the rising population. Furthermore, consanguine marriages in India and China have increased the incidence of genetic disorders amongst humans which has further propelled regional market growth. The rising incidence of genetic disorders and cancers in the US and Canada has given an impetus to the growth of the molecular cytogenetics market in North America.

Some of the key players in the global market for molecular cytogenetics are Applied Spectral Imaging, Abbott Laboratories, Affymetrix, Inc., Illumina, Inc., Agilent Technologies, Inc., and Life Technologies Corporation.

 
The molecular cytogenetics market has grown from $469.2 million in 2012 to an estimated $1.9 billion in 2019 due to the success of techniques such as fluorescence in situ hybridization (FISH) and array comparative genomic hybridization (aCGH). The research report scrutinizes the global market and provides a quantitative and qualitative analysis on the various segments.
 
The report categorizes the overall market on the basis of technology, application and geography. Two main technologies covered are FISH and aCGH. The major areas in which molecular cytogenetics are applied include personalized medicines, cancer, genetic disorders and others. Market size, industry share, forecast, and individual contribution to the global molecular cytogenetics market are provided with respect to every segment. The report helps in understanding the various nuances that make up the industry, the factors that have led to its growth, challenges and hindrances faced, and opportunities for future expansion.
 
It also offers a detailed section on the competitive scenario, including points such as company overview, financial and product portfolios, business strategies and recent developments of the leading players in the industry. 
 
Overview of the molecular cytogenetics market
 
The global molecular cytogenetics market, expected to grow at 23.4% CAGR from 2013-2019, has provided a breakthrough in the fields of research and molecular diagnostics. Earlier restricted to merely identifying chromosome structure, the area of cytogenetics has expanded to assessing structural and functional genetic anomalies. The aCGH technique is currently growing at a CAGR of over 20% compared to FISH technique and is predicted to dominate the market in the forecast period. The main reasons for its rising demand are high resolution, accurate analysis, rapid results and the ability to perform thousands of experiments in a single array, hence saving time and cost.
 
The market for molecular cytogenetics is driven by numerous forces such as rising cases of cancer across the world, increased level of public awareness, mounting popularity of personalized medicines, growing per capita spending capacity, higher R&D activities and laboratories, and use of advanced technology in molecular cytogenetics. Region-wise, North America dominates the global market, followed by Europe. Countries in Asia-Pacific have emerged as potential markets owing to factors such as increasing population and the culture of consanguineous marriage which raises the risk of genetic disorders.
 
A major factor that poses a challenge to the market growth is stringent medical reimbursement.
 
Companies mentioned in the market research report
 
The key market players featured and profiled in the molecular cytogenetics market research report include Affymetrix, Inc., Abbott Laboratories, Applied Spectral Imaging, Agilent Technologies, Inc., Leica Biosystems, Oxford Gene Technology, Life Technologies Corporation, Illumina, Inc., Bio-Rad Laboratories, and SciGene Corporation.
 
This market research report analyzes the following geographies:
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World 
This report gives you access to decisive data such as:
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 
Key highlights of this report
  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements in the micro servers industry
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments
.